A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV.
Epistemonikos ID: 5d07bd3f73f4d72e8dc95a7686f675461aeda8bf
First added on: May 10, 2024